Oftalmolosa Cusí Eritromicina (Erythromycin)

Erythromycin, the active ingredient in Oftalmolosa Cusí Eritromicina, is a macrolide antibiotic presented as a ophthalmic solution for topical eye use. It treats bacterial eye infections and is used in patients of all ages requiring ocular antimicrobial therapy.

GNH USA supplies Oftalmolosa Cusí Eritromicina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oftalmolosa Cusí Eritromicina is a macrolide antibiotic used in ocular infections affecting the conjunctiva, cornea and surrounding tissues. - Bacterial conjunctivitis: Reduces bacterial load and accelerates healing of the conjunctiva. - Bacterial keratitis: Controls infection and supports corneal epithelial recovery. - Post‑surgical ocular prophylaxis: Prevents bacterial contamination after eye surgery.

Adverse reactions to erythromycin ophthalmic preparations are generally mild and localized.

Common Side Effects: - Burning sensation: Temporary discomfort upon instillation. - Stinging or itching: Mild irritation that resolves quickly. - Redness of the conjunctiva: Transient hyperemia. - Tearing: Increased lacrimation after dosing. - Blurred vision: Short‑term visual disturbance. - Foreign‑body sensation: Feeling of grit in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: Swelling, rash, or difficulty breathing. - Corneal ulceration: Persistent epithelial defect or ulcer. - Vision loss: Sudden decrease in visual acuity. - Persistent pain: Ongoing ocular discomfort beyond initial irritation.

When using erythromycin eye drops, consider the following precautions to ensure safe and effective therapy. - Allergy assessment: Verify no known hypersensitivity to macrolides or formulation excipients. - Contact lens wearers: Remove lenses before instillation and wait before reinserting. - Concomitant ocular meds: Separate administration times to avoid dilution. - Pediatric use: Adjust dosing frequency as directed by a clinician. - Pregnancy and lactation: Use only if clearly needed and prescribed. - Store at below 25°C: Keep in the original container, protect from moisture and direct sunlight.

Erythromycin ophthalmic solution may interact with other ocular medications and systemic drugs that affect the eye.

Major Interactions (Avoid): - Anticholinergic eye drops: May reduce drug absorption. - Topical corticosteroids: Increased risk of secondary infection.

Moderate Interactions (Monitor Closely): - Systemic macrolides: Potential additive systemic exposure. - Antihistamine eye drops: May exacerbate dryness. - Non‑steroidal anti‑inflammatory eye drops: Possible irritation increase.